spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CoreValve 

 HSMN NewsFeed - 3 May 2021
Medtronic Announces CE Mark of Evolut(TM) PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Apr 2020
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex(TM) Aortic Valve Technology
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Sep 2017
Magenta Medical, Developer of Novel Heart Failure Therapies, Secures $15 Million in Series B Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 16 May 2017
The Boston Scientific LOTUS(TM) Valve System Demonstrated Superior Efficacy to CoreValve(R) in Global REPRISE III Trial at One Year
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Dec 2016
Essential Medical Inc. Announces the Successful Initiation of the U.S. MANTA Vascular Closure Device Trial With the First Patients Enrolled in TAVR and EVAR Cases
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2014
Edwards Lifesciences, Medtronic Agree to Global Transcatheter Valve Litigation Settlement
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 17 Jan 2014
Medtronic CoreValve(R) System Obtains Early FDA Approval on Exceptional Clinical Performance
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Jan 2014
Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 15 Jan 2014
Medtronic to Appeal Federal District Court Verdict
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 14 Nov 2013
Medtronic to Resume Sales of CoreValve System in Germany
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 17 Oct 2013
Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2013
NDC Appoints Dan Lemaitre to the Board of Directors
Devices Interventional Personnel
 HSMN NewsFeed - 1 Oct 2012
Endologix Appoints Charles Love Vice President of Clinical Affairs
Devices Interventional Personnel
 HSMN NewsFeed - 16 May 2012
STENTYS Self-Apposing(R) Stent shows very low mortality at one month in 1,000 high-risk heart attack patients
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Nov 2011
Medtronic Begins Transcatheter Aortic Valve Trial in Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2011
Study Shows Medtronic CoreValve(R) System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2011
Positive Clinical Outcomes Reported with Medtronic CoreValve(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2011
Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Apr 2011
Globus Medical Appoints Daniel Lemaitre to Its Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 28 Mar 2011
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Mar 2011
STENTYS Expands Operations into Four Additional European Countries
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2011
Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Feb 2011
CardiAQ Valve Technologies (CVT) appoints Dr. Kalathi Thyagarajan as Vice President of Regulatory Affairs & Quality Assurance
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Feb 2011
Medtronic Issues Statement on District Court Ruling Regarding CoreValve
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 18 Jan 2011
Medtronic Revises Design of CoreValve(R) U.S. Pivotal Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jan 2011
St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jan 2011
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 9 Dec 2010
STENTYS begins large-scale, "real life" study with its self-apposing stent for treatment of Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Dec 2010
Medtronic CoreValve(R) System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 Nov 2010
Uptake Medical Names J.C. MacRae as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 15 Oct 2010
Medtronic Clinical Trial Receives FDA Approval to Evaluate New CoreValve(R) System for Aortic Valve Implantation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Sep 2010
Stentys Self-Apposing Stent Proves Superior to Conventional Treatment of Acute Myocardial Infarction
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2010
Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Jul 2010
Stentys completes enrollment in clinical study of its breakthrough stent to treat Acute Myocardial Infarction
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2010
CardiAQ Valve Technologies ("CVT") Completes Move of Its Headquarters to a Specialized Facility in Irvine, Calif., and Announces Expansion of Its Product Development Team
Devices Interventional Cardiology
 HSMN NewsFeed - 27 May 2010
NOXXON Pharma AG raises 33 million in Series D Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 May 2010
Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve(R) Transcatheter Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2010
Medtronic to Appeal Jury Verdict in U.S. Patent Case Involving CoreValve(R) Transcatheter Aortic Valve System
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 1 Apr 2010
Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 12 Mar 2010
Medtronic Starts International Study of CoreValve(R) Transcatheter Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 5 Mar 2010
Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Feb 2010
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Feb 2010
German Appellate Court Affirms Edwards Lifesciences' Transcatheter Valve Patent Not Infringed by CoreValve
Devices Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2010
German Appeals Court Says CoreValve Devices From Medtronic Do Not Infringe Edwards Lifesciences' Andersen Patent
Devices Cardiology Litigation
 HSMN NewsFeed - 19 Jan 2010
Edwards Lifesciences' Transcatheter Valve Patent Found Valid in German Court
Devices Cardiology Litigation
 HSMN NewsFeed - 12 Jan 2010
CardiAQ Valve Technologies (CVT) Closes $6.5 Million 'Series A' Funding for Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 4 Dec 2009
First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Stentys Discloses Results for World's First Clinical Study to Treat Acute Myocardial Infarction (AMI) with a Self-Expanding Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2009
Stentys appoints Vice President of Sales and Marketing
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Jul 2009
Stentys receives CE Mark approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 May 2009
Medtronic's CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2009
Stentys Establishes U.S. Operations in Princeton, N.J.
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Apr 2009
Medtronic Completes Acquisition of CoreValve Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2009
Medtronic to Acquire CoreValve, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2009
Medtronic Acquires Ventor Technologies Ltd.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2009
Edwards Lifesciences' Transcatheter Valve Patent Found Valid in UK Court
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 16 Oct 2008
German Court Finds Edwards Lifesciences' Transcatheter Valve Patent Not Infringed by CoreValve
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 16 Oct 2008
CoreValve Wins Patent Infringement Action in Germany
Devices Cardiology Litigation
 HSMN NewsFeed - 13 Oct 2008
CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving(R) System for Percutaneous Aortic Valve Replacement (PAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Sep 2008
CoreValve Announces Successful Completion of Initial Series of Proctored Cases in Australia and New Zealand Using Its ReValving(R) System for Percutaneous Aortic Valve Replacement
Devices Cardiology
 HSMN NewsFeed - 28 Aug 2008
CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving(R) System for Percutaneous Aortic Valve Replacement
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2008
CoreValve announces that more than 1,000 high-risk patients have been treated with its ReValving(R) System for percutaneous aortic valve replacement (PAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 2 May 2008
CoreValve Names Vito A. Canuso III as Vice President, Intellectual Property
Devices Cardiology Personnel
 HSMN NewsFeed - 30 Apr 2008
CoreValve Names Daniel T. Lemaitre as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 19 Mar 2008
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Feb 2008
CoreValve Refutes Alleged Patent Infringement Action by Edwards Lifesciences
Devices Cardiology Litigation
 HSMN NewsFeed - 12 Feb 2008
Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
Devices Cardiology Litigation
 HSMN NewsFeed - 7 Jan 2008
CoreValve announces that more than 500 high-risk patients have been treated with its ReValving(R) System for percutaneous aortic valve replacement (PAVR)
Devices Cardiology
 HSMN NewsFeed - 12 Nov 2007
Orexo Acquires Biolipox
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2007
CoreValve's 18-French ReValving(TM) System for percutaneous aortic valve replacement (PAVR) demonstrated 'live' at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2007
Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve
Devices Cardiology Litigation
 HSMN NewsFeed - 28 Mar 2007
CoreValve Completes $33 Million Private Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 21 Feb 2007
Stentys Appoints Luc Morisset as Director of Regulatory Affairs
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 18 Jan 2007
CoreValve Announces the Appointment of Dolf Meewis as Vice President of International Sales
Devices Cardiology Personnel
 HSMN NewsFeed - 4 Jan 2007
Stentys Receives 'Seed' Financing From Sofinnova Partners
Devices Venture Capital Interventional Cardiology
 HSMN NewsFeed - 6 Dec 2006
CoreValve announces that its 18-French ReValving(TM) Phase III international clinical trial is now one-third enrolled since commencing less than three months ago
Devices Cardiology
 HSMN NewsFeed - 30 Nov 2006
CoreValve Establishes Revalving(Tm) as Repeatable, Pure Cath-Lab Procedure for PAVR on a Beating Heart: No Cardiac Assistance (Neither Mechanical Assistance, Drug-Induced Hypotension or Rapid Pacing) and No Surgical Vessel Cut-Down
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Nov 2006
First Percutaneous Aortic Valve Replacement (PAVR) Procedure without Any Cardiac Support (i.e., Mechanical Assistance or Accelerated Pacing) Performed with CoreValve's Non-Surgical ReValving(TM) System
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2006
CoreValve's 18-French Revalving(TM) System Demonstrated 'Live' at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Oct 2006
CoreValve announces successful completion of world's first 'pure' percutaneous aortic valve replacement (PAVR) procedure utilizing its patented ReValving(TM) system
Devices Cardiology
 HSMN NewsFeed - 21 Sep 2006
MIV Therapeutics Appoints Montreal Heart Institute Interventional Cardiologist Dr. Raoul Bonan to Guide Clinical Programs
Devices Personnel
 HSMN NewsFeed - 12 Jul 2006
CoreValve reports new milestone: ReValving(TM) procedures are performed (a) without extracorporeal bypass, (b) without respiratory assistance, and (c) without intubation and full anesthesia
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jun 2006
CoreValve Completes Enrollment of Its 'second-generation 21-French' ReValving(TM) System International Clinical Trial for Non-Surgical Replacement of the Diseased Aortic Heart Valve of Patients Not Eligible for Open-Heart Surgery
Devices Cardiology
 HSMN NewsFeed - 11 May 2006
CoreValve Announces 18-French-sized Percutaneous Aortic Valve Replacement (PAVR) Breakthrough Utilizing Its Patented ReValving(TM) System to Non-Surgically Deliver a New Porcine Pericardium Heart Valve over a Severely Diseased Aortic Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Mar 2006
CoreValve names J. C. MacRae as Vice President of Finance and Chief Financial Officer
Devices Cardiology Personnel
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
CoreValve
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.